Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age

New England Journal of Medicine

Volumn 359, Issue 24, 2008, Pages 2521-2532

  Bejon, Philip ^a,b,k   Lusingu, John ^c,d,e   Olotu, Ally ^a   Leach, Amanda ^f   Lievens, Marc ^f   Vekemans, Johan ^f   Mshamu, Salum ^c,d   Lang, Trudie ^a   Gould, Jayne ^d,g   Dubois, Marie Claude ^f   Demoitié, Marie Ange ^f   Stallaert, Jean Francois ^f   Vansadia, Preeti ^h   Carter, Terrell ^h   Njuguna, Patricia ^a   Awuondo, Ken O ^a   Malabeja, Anangisye ^c,d   Abdul, Omar ^c,d   Gesase, Samwel ^c,d   Mturi, Neema ^a   Drakeley, Chris J ^d,g   Savarese, Barbara ^h   Villafana, Tonya ^h   Ballou, W Ripley ^f   Cohen, Joe ^f   Riley, Eleanor M ^d,g   Lemnge, Martha M ^c,d   Marsh, Kevin ^a,b   Von Seidlein, Lorenz ^d,g,i,j   more..

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^d Joint Malaria Programme   (Tanzania)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^h Program for Appropriate Technology in Health PATH Malaria Vaccine Initiative   (United States)

ⁱ International Vaccine Institute   (South Korea)

^j MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT   (Thailand)

^k KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGICAL ADJUVANT; MALARIA VACCINE; RABIES VACCINE;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; DECREASED APPETITE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG FEVER; FEBRILE CONVULSION; FEMALE; FEVER; FOLLOW UP; HUMAN; INFANT; IRRITABILITY; KENYA; LICENCE; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MULTICENTER STUDY; PARASITEMIA; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TANZANIA; UNCONSCIOUSNESS;

EID: 57649115306     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0807381     Document Type: Article

References (26)

1. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005;434:214-7.
2. Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis 2004;4:327-36.
3. Snow RW, Craig M, Deichmann U, Marsh K. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ 1999;77:624-40.
4. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev 2004;2:CD000363.
5. Nosten F, White NJ. Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg 2007;77:Suppl 6:181-92.
6. Okiro EA, Hay SI, Gikandi PW, et al. The decline in paediatric malaria admissions on the coast of Kenya. Malar J 2007;6:151.
7. O'Meara WP, Mwangi TW, Williams TN, McKenzie FE, Snow RW, Marsh K. Relationship between exposure, clinical malaria, and age in an area of changing transmission intensity. Am J Trop Med Hyg 2008;79:185-91.
8. Barnes KI, Durrheim DN, Little F, et al. Effect of artemether- lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med 2005;2(11):e330.
9. Bhattarai A, Ali AS, Kachur SP, et al. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med 2007;4(11):e309.
10. Nyarango PM, Gebremeskel T, Mebrahtu G, et al. A steep decline of malaria morbidity and mortality trends in Eritrea between 2000 and 2004: the effect of combination of control methods. Malar J 2006;5:33.
11. Greenwood BM, Fidock DA, Kyle DE, et al. Malaria: progress, perils, and prospects for eradication. J Clin Invest 2008;118:1266-76.
12. Bojang KA, Milligan PJ, Pinder M, et al. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 2001;358:1927-34.
13. Aponte JJ, Aide P, Renom M, et al. Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial. Lancet 2007;370:1543-51.
14. Alonso PL, Sacarlal J, Aponte JJ, et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 2004;364:1411-20.
15. Garçon N, Chomez P, Van Mechelen M. GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives. Expert Rev Vaccines 2007;6:723-39.
16. Mettens P, Dubois PM, Demoitié MA, et al. Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen. Vaccine 2008;26:1072-82.
17. Stewart VA, McGrath SM, Dubois PM, et al. Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone. Infect Immun 2007;75:2283-90.
18. MedDRA, version 11.1. Geneva: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), 2008.
19. Alonso PL, Sacarlal J, Aponte JJ, et al. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Lancet 2005;366:2012-8.
20. Binka FN, Hodgson A, Adjuik M, Smith T. Mortality in a seven-and-a-half-year follow-up of a trial of insecticide-treated mosquito nets in Ghana. Trans R Soc Trop Med Hyg 2002;96:597-9.
21. Nevill CG, Some ES, Mung'ala VO, et al. Insecticide-treated bednets reduce mortality and severe morbidity from malaria among children on the Kenyan coast. Trop Med Int Health 1996;1:139-46.
22. Snow RW, Korenromp EL, Gouws E. Pediatric mortality in Africa: Plasmodium falciparum malaria as a cause or risk? Am J Trop Med Hyg 2004;71:Suppl 2:16-24.
23. Nyakeriga AM, Troye-Blomberg M, Chemtai AK, Marsh K, Williams TN. Malaria and nutritional status in children living on the coast of Kenya. Am J Clin Nutr 2004;80:1604-10.
24. Sun P, Schwenk R, White K, et al. Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma. J Immunol 2003;171:6961-7.
25. Reece WH, Pinder M, Gothard PK, et al. A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat Med 2004;10:406-10.
26. Okech BA, Corran PH, Todd J, et al. Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia. Infect Immun 2004;72:1557-67.